Literature DB >> 8685038

Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas.

S Luna-Moré1, F de los Santos, J J Bretón, M A Cañadas.   

Abstract

Tests for estrogen (ER) and progesterone (PR) receptors, c-erbB-2, p53 and Bcl-2 were made on paraffin sections of thirty-three cases of invasive micropapillary carcinoma (MPCa) of the breast. The relations between these proteins and general parameters and the patients' evolution, were analyzed and their statistical significance determined by Fisher's exact test. Follow up was available on twenty one patients of whom thirteen were alive after a mean of sixty months. Tumor size, metastatic nodes, c-erbB-2 and Bcl-2 all showed higher values in the dead patient group, but only nuclear grade and extensive lymphatic vessel invasion (LVI) were statistically significant prognostic factors. Hormone receptors and oncogenes were positive in quite similar figures to those of common breast cancers (NOSCa) and offered supplementary information about differentiation and cell atypia of individual cancers. Accordingly, ER (72.7%), PR (45.4%) and Bcl-2 (69.6%) were directly interrelated and inversely related with nuclear grade, mitotic grade, c-erbB-2 (36.3%) and p53 (12.1%). In conclusion, MPCa is a lymphotropic cancer phenotype whose prognosis can be influenced by known prognostic factors, including molecular. The lack of discriminative power between MPCa and NOSCa of ER, PR, c-erbB-2, p53, and Bcl-2 reinforces the importance of recognizing this particular type of cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8685038     DOI: 10.1016/S0344-0338(96)80126-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.

Authors:  Guanqiao Li; Shiping Yang; Jia Yao; Zhenping Wang; Guangyu Yao; Mingfeng Liu; Changsheng Ye
Journal:  World J Surg Oncol       Date:  2016-08-05       Impact factor: 2.754

2.  HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.

Authors:  Sophie Doublier; Dimas C Belisario; Manuela Polimeni; Laura Annaratone; Chiara Riganti; Elena Allia; Dario Ghigo; Amalia Bosia; Anna Sapino
Journal:  BMC Cancer       Date:  2012-01-04       Impact factor: 4.430

3.  Imaging findings of invasive micropapillary carcinoma of the breast.

Authors:  Se Un Yun; Bo Bae Choi; Kwang Sun Shu; Seong Min Kim; Young Duk Seo; Jin Sun Lee; Eil Sung Chang
Journal:  J Breast Cancer       Date:  2012-03-28       Impact factor: 3.588

4.  Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.

Authors:  María F Mercogliano; Gloria Inurrigarro; Mara De Martino; Leandro Venturutti; Martín A Rivas; Rosalía Cordo-Russo; Cecilia J Proietti; Elmer A Fernández; Isabel Frahm; Sabrina Barchuk; Daniel H Allemand; Silvina Figurelli; Ernesto Gil Deza; Sandra Ares; Felipe G Gercovich; Eduardo Cortese; Matías Amasino; Pablo Guzmán; Juan C Roa; Patricia V Elizalde; Roxana Schillaci
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

5.  The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.

Authors:  Yun Wu; Ning Zhang; Qifeng Yang
Journal:  BMC Cancer       Date:  2017-12-11       Impact factor: 4.430

6.  Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.

Authors:  Fu-Gui Ye; Chen Xia; Ding Ma; Pei-Yang Lin; Xin Hu; Zhi-Ming Shao
Journal:  BMC Cancer       Date:  2018-11-08       Impact factor: 4.430

7.  Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.

Authors:  Shuang Hao; Yuan-Yuan Zhao; Jin-Juan Peng; Fei Ren; Wen-Tao Yang; Ke-Da Yu; Zhi-Ming Shao
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

8.  Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues.

Authors:  Chao Shen; Meijia Gu; Dan Liang; Lixia Miao; Liu Hu; Congyi Zheng; Jiakuan Chen
Journal:  Cancer Cell Int       Date:  2009-01-02       Impact factor: 5.722

9.  Postoperative radiotherapy for invasive micropapillary carcinoma of the breast: an analysis of Surveillance, Epidemiology, and End Results database.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Yong-Xiong Chen; Zhen-Yu He
Journal:  Cancer Manag Res       Date:  2017-10-03       Impact factor: 3.989

10.  Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study.

Authors:  Xin Guan; Guiying Xu; Aiping Shi; Yabin Zou; Yue Zhan; Zhimin Fan; Yi Dong
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.